We advise healthcare innovators on the regulatory, reimbursement, and adoption pathways between discovery and the market.
Getting healthcare
innovation to patients.
By Jonathan Ketcham
Selected clients
✦ Founder profile
Healthcare strategy grounded in economics, policy, and market reality
Jonathan Ketcham brings three decades of experience in healthcare economics research, teaching, and advising, with collaborations across government, industry, and academia.
As a distinguished professor at Arizona State University and former Chief Healthcare Economist at the White House Council of Economic Advisers, he has advised on healthcare economic policy across the entire executive branch of the US government, including CMS, FDA, NIH, and ARPA-H.
Margin Health brings that experience into focused advisory work for healthcare innovators navigating regulatory strategy, reimbursement, evidence generation, and market adoption.
✦ Services
✦ Founder profile
THREE DECADES OF HEALTHCARE ECONOMICS
Jonathan earned his PhD from Wharton and served as Chief Healthcare Economist in the Executive Office of the President, advising on healthcare economic policy across the entire executive branch of the US government, including the HHS agencies FDA, CMS, NIH, and ARPA-H. He has also served as principal economist on Amazon’s employee benefits team. His advisory work is built on three decades of peer-reviewed econometrics research.
The experience behind the advisory practice
01
FEDERAL HEALTHCARE POLICY & REGULATORY ECONOMICS
White House Council of Economic Advisers • FDA, CMS, NIH & ARPA-H
Jonathan Ketcham served as Chief Healthcare Economist at the White House Council of Economic Advisers, advising on healthcare economic policy across HHS and its operating divisions, including the FDA, CMS, NIH, and ARPA-H.
02
HEALTHCARE ECONOMICS & MARKET DESIGN
Arizona State University • W. P. Carey School of Business
As the Earl G. and Gladys C. Davis Distinguished Research Professor in Business at ASU, Ketcham’s work sits at the intersection of health economics, consumer behavior, and public policy. His research uses causal-inference methods and large-scale real-world data to study how incentives, information, and institutional design influence decisions by payers, providers, and patients.
03
INDUSTRY ADVISORY & COMMERCIAL HEALTHCARE STRATEGY
Amazon, CMS, Pfizer, Banner Health, CVS Caremark & others
Ketcham has more than two decades of healthcare economics experience across research, teaching, and consulting. His work has touched pharmaceutical strategy, pharmacy benefit managers, health insurance, consumer and physician decision-making, hospital pricing, provider incentives, payment methods, employee benefits, and valuation of health outcomes.
04
MARGIN HEALTH REGULATORY, REIMBURSEMENT & ADOPTION PATHWAYS
Founder • Healthcare Advisory
Margin Health helps leaders across private industry, government, and financial markets navigate the regulatory, reimbursement, and adoption pathways that turn healthcare innovation into operational and commercial deployment. The firm is positioned for healthcare innovators who need strategy grounded in evidence, economics, and policy reality.
✦ Testimonials
Words That Matter - Real Experiences from Real Collaborations
Years of healthcare economics experience across research, teaching, consulting, and policy advisory
✦ Research and publications
The research behind the advice
Margin Health is grounded in rigorous, peer-reviewed research.
As a distinguished professor at Arizona State University and former Chief Healthcare Economist at the White House Council of Economic Advisers, he has advised on healthcare economic policy across HHS divisions including FDA, CMS, NIH, and ARPA-H.
One publication is featured for now — more coming soon.
LET’S TURN HEALTHCARE EVIDENCE INTO MARKET STRATEGY.
Location
Phoenix | Telluride